Microarray and histopathological analysis of tumours: the future and the past?
- 1 November 2001
- journal article
- research article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 1 (2) , 151-157
- https://doi.org/10.1038/35101087
Abstract
The excitement surrounding the development of DNA microarray analysis and proteomics has raised questions about the role of these techniques in clinical practice and patient management. But how did the traditional methods of cancer diagnosis and prognosis develop, and how can high-throughput techniques contribute?Keywords
This publication has 17 references indexed in Scilit:
- CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiationBritish Journal of Cancer, 2001
- Microarrays—the 21st century divining rod?Nature Medicine, 2001
- Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networksNature Medicine, 2001
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breastEuropean Journal Of Cancer, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- High-throughput polymorphism screening and genotyping with high-density oligonucleotide arraysGenetic Analysis: Biomolecular Engineering, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐upHistopathology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991